Dawaa Reference

Drug profile

Clobetasol Propionate

Adult, child, renal, hepatic, pregnancy and breastfeeding information, with the source named on every line.

DRUG INFORMATION

  ADULT
    - Clobetasol Propionate Shampoo, 0.05% is for topical use only, and not for
      ophthalmic, oral or intravaginal use. Clobetasol Propionate Shampoo, 0.05% should
      be applied onto dry (not wet) scalp once a day in a thin film to the affected
      areas only, and left in place for 15 minutes before lathering and rinsing. The
      total dosage should not exceed 50 g (50 mL or 1.75 fl. oz.) per week.
      Source: US FDA label for clobetasol propionate (clobetasol propionate), section
      'dosage and administration', retrieved 2026-08-29

  CHILD
    - Use of clobetasol propionate shampoo, 0.05% in patients under 18 years old is not
      recommended due to potential for HPA axis suppression [see Warnings and
      Precautions ( 5.1 )] The effect of clobetasol propionate shampoo, 0.05% on HPA
      axis suppression was evaluated in one trial in adolescents 12 to 17 years of age
      with moderate to severe scalp psoriasis with involvement of at least 25% of the
      scalp.
      Source: US FDA label for clobetasol propionate (clobetasol propionate), section
      'pediatric use', retrieved 2026-08-29

  RENAL IMPAIRMENT
    - No kidney-impairment dose in this label. Not a statement that none is needed.
      Source: Read and found silent: the US FDA label for clobetasol propionate
      (clobetasol propionate), retrieved 2026-08-29

  HEPATIC IMPAIRMENT
    - Factors that predispose a patient using a topical corticosteroid to HPA axis
      suppression include the use of more potent steroids, use over large surface areas,
      use over prolonged periods, use under occlusion, use on an altered skin barrier,
      and use in patients with liver failure.
      Source: US FDA label for clobetasol propionate (clobetasol propionate), section
      'warnings and cautions', retrieved 2026-08-29

  PREGNANCY   [ CAUTION ]
    The label allows it only when the benefit is judged to outweigh the risk. Read the
      quote below.
    - Teratogenic effects: Pregnancy Category C.
      Source: US FDA label for clobetasol propionate (clobetasol propionate), section
      'pregnancy', retrieved 2026-08-29
    - There are no adequate and well-controlled studies in pregnant women.
      Source: US FDA label for clobetasol propionate (clobetasol propionate), section
      'pregnancy', retrieved 2026-08-29
    - Therefore, clobetasol propionate shampoo, 0.05% should be used during pregnancy
      only if the potential benefit justifies the potential risk to the fetus.
      Source: US FDA label for clobetasol propionate (clobetasol propionate), section
      'pregnancy', retrieved 2026-08-29

  BREASTFEEDING   [ CAUTION ]
    The label allows it only when the benefit is judged to outweigh the risk. Read the
      quote below.
    - Systemically administered corticosteroids appear in human milk and could suppress
      growth, interfere with endogenous corticosteroid production, or cause other
      untoward effects.
      Source: US FDA label for clobetasol propionate (clobetasol propionate), section
      'nursing mothers', retrieved 2026-08-29
    - It is not known whether topical administration of corticosteroids could result in
      sufficient systemic absorption to produce detectable quantities in human milk.
      Source: US FDA label for clobetasol propionate (clobetasol propionate), section
      'nursing mothers', retrieved 2026-08-29
    - Because many drugs are excreted in human milk, caution should be exercised when
      clobetasol propionate shampoo, 0.05% is administered to a nursing woman.
      Source: US FDA label for clobetasol propionate (clobetasol propionate), section
      'nursing mothers', retrieved 2026-08-29